Interleukin-5 (IL-5) promotes the grgwth and differentiation of human eosinophils and may regulate the selective eosinophilia and eosinophil activation seen in certain diseases. Radiolabeled recombinant human IL-5 (hlL-5) was used t o characterize the 11-5 receptor present on normal human eosinophils and on the myeloid leukemia line HL-60, which can be induced t o differentiate into eosinophilic cells. Binding studies with eosinophils and HL-60 cells grown under alkaline conditions demonstrated similar high-affinity binding sites for hlL-5 on both cell types with kd values of -400 pmol/L. The binding observed was specific in that it was not inhibited by hlL-3, human granulocyte-macrophage colonystimulating factor, or hlL-2. Binding studies with a number of other human cell lines, including a B-lymphoma line, and with lymphocyte and neutrophil preparations were also performed, but IL-5 receptors were not detectable on these cells. The number of hlL-5 receptors on HL-60 cells could be OSINOPHILS are present in relatively low numbers in E the blood of healthy individuals, but their numbers increase dramatically in certain diseases, such as parasite infections, and in allergic states such as asthma. Interleukin-5 (IL-5) appears to specifically promote eosinophil growth and differentiation and it may regulate the selective eosinophilia and eosinophil activation seen in disease.I4 Apart from its activity on the eosinophil lineage, 1L-5 also has T-cell-replacing factor activity and B-cell growth factor activity on mouse B cells: but it does not have similar activities on human B cells.6 Previous studies with several IL-5-responsive mouse B-cell lines have demonstrated both high-affinity (kd 60 to 150 pmoVL) and low-affinity (kd 12 to 27 nmol/L) binding sites for mouse IL-5, and crosslinking studies have identified putative receptor proteins of -55 Kd and -125 Kd.' Much less is known about the IL-5 receptor on eosinophils partly due to a lack of suitable IL-5-responsive eosinophil cell lines and the difficulties of obtaining suitable quantities of eosinophils from healthy individuals.
OSINOPHILS are present in relatively low numbers in E the blood of healthy individuals, but their numbers increase dramatically in certain diseases, such as parasite infections, and in allergic states such as asthma. Interleukin-5 (IL-5) appears to specifically promote eosinophil growth and differentiation and it may regulate the selective eosinophilia and eosinophil activation seen in disease.I4 Apart from its activity on the eosinophil lineage, 1L-5 also has T-cell-replacing factor activity and B-cell growth factor activity on mouse B cells: but it does not have similar activities on human B cells. 6 Previous studies with several IL-5-responsive mouse B-cell lines have demonstrated both high-affinity (kd 60 to 150 pmoVL) and low-affinity (kd 12 to 27 nmol/L) binding sites for mouse IL-5, and crosslinking studies have identified putative receptor proteins of -55 Kd and -125 Kd.' Much less is known about the IL-5 receptor on eosinophils partly due to a lack of suitable IL-5-responsive eosinophil cell lines and the difficulties of obtaining suitable quantities of eosinophils from healthy individuals.
The human promyelocytic leukemia line HL-60 can be induced to differentiate into predominantly eosinophil-like cells,' suggesting that it may carry IL-5 receptors and provide a suitable model for studies of the human IL-5 (hIL-5) receptor. In the present study we have used recombinant hIL-5 prepared in the baculovirus expression system to characterize the hIL-5 receptor present on both the HL-60 cell line and on eosinophils from healthy individuals. The hIL-5 receptors on both cell types were shown to be specific and of high affinity, giving kd values of 400 pmoVL. Cell-bound IL-5 was shown to be associated with a membrane protein of 55 to 60 Kd. Cellular autoradiography of slides prepared from peripheral blood as well as direct binding studies of cell preparations showed that the hIL-5 receptor is only detectable on eosinophils consistent with the specific action of IL-5 on the human eosinophil lineage.
correlated with its propenqity t o differentiate towards an eosinophilic cell type. Expression of hlL-5 receptors on HL-60 cells was upregulated by butyric acid under alkaline conditions, downregulated by hlL-3, virtually eliminated by dimethyl sulfoxide and hlL-5, while hlL-2 had no detectable effect. One major '%hlL-5-crosslinked complex of 75 t o 85 Kd in Mr was detected on HL-60 cells using crosslinking agents giving a molecular mass of 55 t o 60 Kd for the hlL-5 receptor itself.
Studies using cellular autoradiography showed that IL-5 receptors were evenly distributed on eosinophils but that receptor distribution on HL-60 cells was noticeably heterogeneous. Eosinophils were the only cells in slides prepared from peripheral blood that had detectable levels of IL-5 receptors in agreement with the specific action of IL-5 on the human eosinophil lineage.
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MATERIALS AND METHODS
The cell lines K562, 8866, and MOLT4 were gifts from H. Warren (Division of Clinical Sciences, John Curtin School of Medical Research [JCSMR], Canberra, Australia). All cell lines were maintained in RPMI-1640 (GIBCO, MD) supplemented with 10% fetal calf serum (FCS) (heat-inactivated), 2 mmol/L glutamine, and antibiotics (penicillin, streptomycin, and gentamycin). The cell lines HL-60, RC2& and U937 were gifts from A. Hapel (Division of Clinical Sciences, JCSMR). HL60 cells were grown under alkaline conditions as described previously.8 Subclones of HL-60 cells were isolated from soft agar cultures grown for 7 days using a finely drawn out pipette as previously described.'
Human eosinophils were isolated from peripheral blood using metrizamide gradients as previously described" with slight modifications. B u m coats were prepared from freshly isolated peripheral heparinized (1,000 U/50 mL) blood by adding 4.5% dextran (19,500 Mr; Sigma, St Louis, MO) in phosphate-buffered saline (PBS) to a final concentration of 0.9% and allowing the mixture stand for 45 minutes at 37°C. Cells from the bum coat were washed several times in culture medium before being resuspended at 1 x 108/mL in medium. The cells were then layered onto a six-step gradient (24%, 23%, 22%, 21%, 20%, and 18%) of metrizamide (Sigma) in Tyrode's salt solution'" containing 0.02% gelatin (type 225; Sigma). The gradients were centrifuged at 1,00(% for 45 minutes at room temperature. Eosinophils were recovered from the cell pellet and
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the 24% to 23% and 23% to 22% interfaces. Neutrophils were isolated from the 20% to 21% interface and lymphocytes were isolated from the 18% to 20% interface. After several washes in medium, contaminating erythrocytes were eliminated by water lysis. The isolated eosinophils were greater than 80% pure, with neutrophils being the main contaminating cell type, and were cultured in the above medium. Neutrophils were greater than 97% pure, with eosinophils being the main contaminant.
For the eosinophil maintenance assay, eosinophils were plated at 5 x lo4 cells per well (200 pL) in flat-bottom 96-well plates (Nunc, Denmark). Eosinophil survival was measured after 2 days of incubation at 37"C/5%C02 by trypan blue exclusion.
Recombinant hIL-5 was prepared as previously described'' from supernatants of Sf9 cells infected with a recombinant baculovirus producing hIL-5 and had a specific activity of 2.4 X lo7 Uimg in a human eosinophil maintenance assay. The hIL-5 was purified to homogeneity using hydrophobicity (phenylsepharose), anion exchange (MonoQ), and gel filtration (sephadex G-100) chromatography. Recombinant hIL-3 and natural human granulocyte-macrophage colony-stimulating factor (hGM-CSF) were gifts from M-C. Fung (Division of Clinical Sciences, JCSMR).
Recombinant hIL-5 purified to homogeneity from the baculovirus system was iodinated to high specific activity with Bolton and Hunter reagent (Amersham, UK, diiodo derivative, 4,000 Ciimmol) using the following procedure. Five micrograms of hIL-5 in 10 pL of PBS/0.02% Tween-20 was incubated with 1 mCi of dried-down Bolton and Hunter reagent for 2 to 6 hours at 4°C. The reaction was stopped by the addition of 25 pL of 0.5 mol1L glycine in PBS/0.02% Tween-20 and the mixture held for 5 minutes at 4°C. The sample volume was then adjusted to 100 pL with PBS/O.O2% Tween-20 and loaded onto a NICK column (Amersham, sephadex G-50) that had been washed with 1 mL of RPMI-1640110% FCS and then equilibrated with PBS1 0.02% Tween-20. Radiolabeled hIL-5 was separated from unincorporated material according to the manufacturers instructions. The recovery of hIL-5 using the standardized separation procedure was determined using the Bio-Rad (Australia) protein assay kit and shown to be -75%. The level of incorporation was measured in a y-counter (Packard Auto-Gamma 5650; Australia). Sodium dodecy1 sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the iodinated hIL-5 preparation followed by autoradiography showed that the iodinated species had an apparent molecular mass of 30 Kd, as expected for the hIL-5 dimer, and of 15 Kd as a monomer after reduction. Specific radioactivities of the iodinated hIL-5 ranged from 2 to 7 x lo7 CPMlpg. When tested in the eosinophil maintenance assay, radiolabeled hIL-5 retained greater than 90% of its biologic activity. Radiolabeled hIL-5 was stable when stored at 4°C in PBSiTween-20 for up to 7 days, although preparations were generally used within 5 days of iodination.
Cells to be assayed for hIL-5 binding were washed twice with binding medium (RPMI-1640110% FCS12 mmol/L glutamine/antibiotics). after which the cells were resuspended in binding medium and equilibrated at 4°C before use in binding experiments. Except where specifically stated, binding experiments were performed at 4°C for 2 to 4 hours in binding medium (200 kL) containing 1 X lo6 cells in 1.5-mL Eppendorf tubes. The tubes were gently vortexed every 30 minutes to 1 hour. At the end of the incubation period, the binding mixture was layered over 200 pL of oil mixture (16% parafin oi1/84% silicon oil, type 550) and centrifuged at 12,000 rpm for 2 to 5 minutes to separate unbound IzI-hIL-5 from labeled cells. The tips of the tubes were cut o f f and placed into 5-mL tubes (Falcon, type 2003; NJ) and the radioactivity counted in a y-counter (Packard AutoGamma 5650). Specific binding was defined as the difference between total binding and nonspecific binding in the presence of a
Cytokines.
Iodination ofhlL-5.
Specific binding assays.
100-fold molar excess of unlabeled hIL-5. The dissociation constant and average number of binding sites per cell were calculated by Scatchard analysis of the saturation binding data" using linear regression analysis with the program Cricket-Graph (Cricket Software, PA). The lower limit of detection was -10 binding sites per cell.
The chemical cross-linkers disuccinimidyl suberate (DSS), ethylene glycol bis (succinimidyl succinate) (EGS), and disuccinimidyl tartarate (DST) were purchased from Pierce Chemical Company (Rockford, IL). Cells (2 x lo6 to 1 X lo7) that had been incubated with 1 to 2.5 nmoliL IzI-hIL-5 with or without 100-fold unlabeled hIL-5 for 2 to 4 hours as above were centrifuged and washed once with 1 mL of PBS or Hank's balanced salt solution (HBSS). The cells were then resuspended in 500 pL of PBS or HBSS and 10 pL of cross-linker (50 mmoliL in dimethyl sulfoxide [DMSO] ) was added to give a final concentration of 1 mmol/L, and the mixture was incubated at 4°C for 30 minutes. The cells were washed twice with 1 mL of PBS or HBSS before being resuspended in 50 to 150 LL of PBS containing 1% Triton X-100, 2 mmol/L EGTA, 2 mmol1L EDTA, 2 mmoUL phenylmethylsulfonyl fluoride (PMSF), 10 pmol/L pepstatin, 10 pmol/L leupeptin, 2 mmol1L o-phenanthroline, and 200 Kallikrein units (K1U)lmL aprotinin. The lysate was incubated at room temperature for 5 to 15 minutes and then centrifuged at 12,000 rpm for 5 minutes and the supernatant was analyzed by SDS-PAGE using a discontinuous buffer system." Gels were silver stained," dried down using a vacuum slab gel drier, and exposed to Kodak XAR-5 X-ray film (Eastman Kodak, Sydney, Australia) at -70°C with two intensifying screens for 2 to 8 weeks.
Cells were incubated with 1 to 2.5 nmoliL '*jI-hIL-5 as above then washed twice with 1 mL of binding medium and resuspended at 2 x 10"imL in binding medium. Cells (50 pL) were centrifuged onto glass slides in a cytocentrifuge (Cytospin 2, Shandon, England), air-dried, and fixed in 50% methanol for 5 seconds. After air-drying, slides were dipped in Kodak NTB-2 photographic emulsion at 45°C in a dark room and allowed to dry in a vertical position. Slides were sealed in light-proof boxes with drierite and allowed to expose at 4°C for 2 to 6 weeks. Slides were then warmed to room temperature, developed for 5 minutes in Kodak D19 developer (40 @500 mL water), washed in water for 1 minute, fixed in Agfa G333c X-ray h e r containing aditan hardener (25 mL/L) for 5 minutes, and then washed in water for 5 minutes. After air-drying, slides were stained with Wright-Geimsa stain using an automatic slide stainer (Ames, Hema-Tek, Miles, IN) and then mounted in Depex (BDH, Melbourne, Australia).
Chemical cross-linking. Growth of HL-60 cells under alkaline conditions has been shown to induce the propensity to differentiate into eosinophilic cells and a significant proportion of the population differentiates upon further treatment with butyric acid.8 It was therefore expected that HL-60 cells grown under alkaline conditions would have increased levels of hIL-5 receptors. The effect of time and temperature on 12jI-hIL-5 binding to HL-60 cells grown under alkaline conditions was examined (Fig 1) . I . . . I . . . I . . . , . . . , . . . , . . . I . . . , . . . , . . . I . . binding was observed after 30 minutes, suggesting there is internalization and degradation of the bound '"1-hIL-5. At 4"C, maximum and stable binding was achieved after 2 hours of incubation. From Fig 1, a forward rate constant of 6.68 x 10" mol/L-' Log(min)-' at 4°C was calculated. The reverse rate constant at 4°C was calculated to be 398 Log(min)-'. The ratio of these two rate constants gives an equilibrium binding constant of 590 pmol/L. This finding is in close agreement with the values obtained from equilibrium binding experiments (see below).
Cell autoradiography.
RESULTS
Characterization
The reversibility of the binding of hIL-5 that occurred at 4°C to HL-60 cells was also examined following removal of the free radiolabeled ligand. Approximately 70% of the bound hIL-5 dissociated under these conditions with the rate of dissociation increasing with increasing temperature as expected. Equilibrium binding data was obtained for specific binding of hIL-5 to HL-60 cells with concentrations of hIL-5 up to 10 nmol/L. In this concentration range only a single high-affinity binding site was observed with an equilibrium dissociation constant (kd) of 500 pmol/L. To test the specificity of hIL-5 binding to HL-60 cells, competition experiments were performed in the presence of unlabeled hIL-3, hGM-CSF, and hIL-2, but no inhibition was observed. The lack of competition with hIL-3 and hGM-CSF is particularly significant because both cytokines also stimulate the eosinophil Preparations of human lymphocytes, eosinophils, and neutrophils and five other continuous cell lines of human origin were also examined for their ability to bind L251-hIL-5. Significant binding was seen only on eosinophils (Table 1) (Table 1) . From the population of HL-60 cells it was possible to isolate eosinophilic subclones that possessed relatively high numbers of hIL-5 binding sites (Table  1) . However, subsequent passaging of the subclones over several months resulted in reversion to the characteristics of the parental HL-60 cells in terms of both the number of hIL-5 binding sites (from -1,400 to -200) and the cellular phenotype.
Cytokinesis and chemical inducers' are known to affect the ability of HL-60 cells to differentiate into eosinophilic, neutrophilic, and monocytic cell types. Figure 2 shows the effect, after 6 days incubation, of several cytokines and chemical inducers on the hIL-5 binding sites expressed by HL-60 cells. While hIL-2 had no effect, hIL-3 reduced the number of binding sites by -%. hIL-5 itself eliminated binding of '*'I-hIL-5. Culturing with DMSO (176 pmol/L), which causes HL-60 cells to differentiate into neutrophilic cells, reduced the number of hIL-5 receptors to undetectable levels. Culturing HL-60 cells with butyric acid (0.5 mmol/L) under alkaline conditions (pH 7.7), which is known to cause an eosinophilic differentiation, resulted .in about a doubling of hIL-5 receptor numbers to a level approaching that seen on normal eosinophils.
Receptor distribution studies were also performed using cellular autoradiography. Analysis of individual cells labeled with IZ5I-hIL-5 showed that HL-60 cells do not have an even distribution of hIL-5 receptors. Approximately 25% of the cells have no receptors, 50% have very low numbers of receptors, and the remaining 25% have high numbers of receptors (Fig 3) . Culturing HL-60 cells with butyric acid (0.5 mmol/L) under alkaline conditions (pH 7.7), which induces differentiation into eosinophilic cells, resulted in a Cellular autoradiography of the hIL-5 receptor. Equilibrium binding experiments were performed on various cells and cell lines (1 x 10' cells) with increasing concentrations of radiolabeled hlL-5 in the presence or absence of 100-fold molar excess of unlabeled hlL-5, as described in Materials and Methods. Binding results were analyzed by Scatchard analysis. The HL-60 subclones are arranged in ascending order of increasing eosinophilic phenotype (HL-604 being the most eosinophilic and HL-6018-9 the least).
For Bound (Receptors/Cell) morc cvcn distribution of IL-5 rcccptors, with rcccptor numbcrs approximating thosc on cosinophils. Analysis of pcriphcral blood cosinophils showcd a ncar-cvcn distribution of hIL-5 rcccptors among the cclls (Fig 4) . In slidcs of lymphocytcs, ncutrophils, and cosinophils prcparcd from pcriphcral blood. only cosinophils showcd thc prcscncc of IL-S rcccptors (rcsults not prcscntcd). Cell autoradiography of normal eosinophils and neutrophils. Cells were incubated with 1 t o 2.5 nmollL '"I-hlL-5 as described in Materials and Methods. Cells centrifuged onto glass slides were dipped in Kodak NTB-2 photographic emulsion, as described in Materials and Methods, and exposed at 4 C for 3 weeks. Slides were then developed and stained with Wright-Geimsa and mounted in Depex. The slide was photographed at 1.000x magnification. E, eosinophil; N, neutrophil. nonrcducing gcls and 15 Kd for thc monomer on rcducing gcls) yiclds an cstimation of 55 to 60 Kd for thc Mr of thc hlL-5 binding protcin prcscnt on HL-60 cclls.
DISCUSSION
Thc most wcll documcntcd activity of hIL-5 is its ability to stimulatc thc growth and diffcrcntiation of cosinophil progcnitors.' Activation of human cosinophils by IL-5 has also bcen dcmonstratcd.' In thc prcscnt rcport, ccll autoradiography studics of prcparations from pcriphcral blood showcd that IL-5 rcccptors wcrc only dctcctablc on cosinophils. Binding studics with a numbcr of othcr human ccll lincs, including a R-lymphoma linc, wcrc also pcrformcd but IL-5 rcccptors wcrc only found on HL-60, a ccll linc that can bc induccd to diffcrcntiatc into cosinophilic cclls. Thcsc findings support the postulatcd rolc of hIL-5 in spccifically promoting cosinophil diffcrcntiation and activation.
Binding studics showcd that cosinophils and HL-60 cclls possess similar high-affinity binding sitcs for hIL-5, giving kd valucs of -400 pmol/L. Thc binding obscrvcd was spccific in that it was not inhibitcd by thc prcscncc of hIL-3. hGM-CSF, or hIL-2. hIL-3 and hGM-CSF arc also activc in promoting growth and diffcrcntiation of cosinophils. Rcccptor numbcrs rangcd from 1,000 on human cosinophils to 200 on HL-60 cclls grown undcr alkalinc conditions. The numbcr of hIL-5 rcccptors on HL-60 cclls was corrclatcd with its propcnsity to diffcrcntiatc towards an cosinophilic ccll typc. Exprcssion of hIL-5 rcccptors on HL-60 cclls was uprcgulatcd by butyric acid undcr alkalinc conditions, downrcgulatcd by hIL-3, virtually climinatcd by DMSO and hIL-5, whilc hIL-2 had no dctcctablc cffcct. Ccllular autoradiography studics showcd that hIL-5 rcccptors wcrc not cvcnly distributcd among HL-60 cclls. Somc cclls had high numbcrs whilc most had only a fcw rcccptors. The numbcr of cclls cxprcssing significant numbcrs of hIL-5 rcccptors was incrcascd by trcatmcnts inducing HL-60 to diffcrcntiatc into cosinophilic cclls. In contrast. rcccptor distribution on normal human cosinophils was morc uniform.
Onc major '"I-hIL-5~rosslinkcd complcx of 75 to 85 Kd in Mr was dctcctcd on HL-60 cclls using EGS or DSS, giving a molccular mass of 55 to 60 Kd for thc hIL-5 rcccptor itsclf. Thc singlc high-affinity binding sitc (kd 400 pmol/L) for hIL-5 found on both normal human cosinophils and HL-60 cclls contrasts with prcvious findings with IL-S-dcpcndcnt mousc B-ccll lincs' whcrc both highaffinity (kd 66 to 150 pmol/L) and low-affinity (kd 12 to 27 nmol/L) sitcs wcrc dctcctcd. Similarly, cross-linking studics with mousc B-ccll lincs havc dctcctcd two cross-linked protcin spccics of 47 to 60 Kd and 114 to 137 Kd rathcr than thc singlc cross-linkcd spccics of 55 to 60 Kd dctcctcd in thc prcscnt rcport with HL-60 cclls.
Rcccntly, two studics of thc hIL-5 rcccptor havc been rcportcd.'"" In both caws only a singlc affinity class was found, in agrccmcnt with thc prcscnt work. Howcvcr, thc kd valucs of 30 pmol/L for HL-60 CCIIS'~ and 2.60 pmol/L for normodcnsc cosinophils from paticnts with hypcrcosinophilic syndromcl'diffcr from thc kd valuc of 400 pmol/L for both HL-60 cclls and normal cosinophils rcportcd hcrc. It would bc cxpcctcd that HL-60 cclls and cosinophils would givc vcry similar kd valucs for thc hIL-5 rcccptor as obtaincd in thc prcscnt cxpcrimcnts. It is not clear why thc kd valucs obtaincd in thc diffcrcnt laboratorics for the hIL-5 rcccptor arc so diffcrcnt. Anothcr intcrcsting diffcrcncc is that Plactinck ct al,lh in thcir studics with HL-60. idcntificd two putative hIL-5 rcccptor protcins by crosslinking of 60 Kd and 130 Kd, whcrcas only thc f o r " spccics was found in thc prcscnt work.
